These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 20716635)
21. Akt/cAMP-responsive element binding protein/cyclin D1 network: a novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutine, a Phellodendron amurense bark extract. Kumar AP; Bhaskaran S; Ganapathy M; Crosby K; Davis MD; Kochunov P; Schoolfield J; Yeh IT; Troyer DA; Ghosh R Clin Cancer Res; 2007 May; 13(9):2784-94. PubMed ID: 17473212 [TBL] [Abstract][Full Text] [Related]
22. Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease. Kang BH; Tavecchio M; Goel HL; Hsieh CC; Garlick DS; Raskett CM; Lian JB; Stein GS; Languino LR; Altieri DC Br J Cancer; 2011 Feb; 104(4):629-34. PubMed ID: 21285984 [TBL] [Abstract][Full Text] [Related]
23. Chemopreventive efficacy of inositol hexaphosphate against prostate tumor growth and progression in TRAMP mice. Raina K; Rajamanickam S; Singh RP; Agarwal R Clin Cancer Res; 2008 May; 14(10):3177-84. PubMed ID: 18483386 [TBL] [Abstract][Full Text] [Related]
24. Differential effects of omega-3 PUFAS on tumor progression at early and advanced stages in TRAMP mice. Amaro GM; da Silva ADT; Tamarindo GH; Lamas CA; Taboga SR; Cagnon VHA; Góes RM Prostate; 2022 Dec; 82(16):1491-1504. PubMed ID: 36039485 [TBL] [Abstract][Full Text] [Related]
25. E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse. Wechter WJ; Leipold DD; Murray ED; Quiggle D; McCracken JD; Barrios RS; Greenberg NM Cancer Res; 2000 Apr; 60(8):2203-8. PubMed ID: 10786685 [TBL] [Abstract][Full Text] [Related]
26. High animal fat intake enhances prostate cancer progression and reduces glutathione peroxidase 3 expression in early stages of TRAMP mice. Chang SN; Han J; Abdelkader TS; Kim TH; Lee JM; Song J; Kim KS; Park JH; Park JH Prostate; 2014 Sep; 74(13):1266-77. PubMed ID: 25053105 [TBL] [Abstract][Full Text] [Related]
27. Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. Bono AV; Pannellini T; Liberatore M; Montironi R; Cunico SC; Cheng L; Sasso F; Musiani P; Iezzi M Anal Quant Cytol Histol; 2010 Jun; 32(3):136-45. PubMed ID: 20701066 [TBL] [Abstract][Full Text] [Related]
28. Flavokawain A induces deNEDDylation and Skp2 degradation leading to inhibition of tumorigenesis and cancer progression in the TRAMP transgenic mouse model. Li X; Yokoyama NN; Zhang S; Ding L; Liu HM; Lilly MB; Mercola D; Zi X Oncotarget; 2015 Dec; 6(39):41809-24. PubMed ID: 26497688 [TBL] [Abstract][Full Text] [Related]
29. Chemoprevention of prostate carcinogenesis by alpha-difluoromethylornithine in TRAMP mice. Gupta S; Ahmad N; Marengo SR; MacLennan GT; Greenberg NM; Mukhtar H Cancer Res; 2000 Sep; 60(18):5125-33. PubMed ID: 11016639 [TBL] [Abstract][Full Text] [Related]
30. Lobe-specific lineages of carcinogenesis in the transgenic adenocarcinoma of mouse prostate and their responses to chemopreventive selenium. Wang L; Zhang J; Zhang Y; Nkhata K; Quealy E; Liao JD; Cleary MP; Lü J Prostate; 2011 Sep; 71(13):1429-40. PubMed ID: 21360561 [TBL] [Abstract][Full Text] [Related]
31. Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism. Singh KB; Kim SH; Hahm ER; Pore SK; Jacobs BL; Singh SV Carcinogenesis; 2018 May; 39(6):826-837. PubMed ID: 29668854 [TBL] [Abstract][Full Text] [Related]
32. Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression. Anzo M; Cobb LJ; Hwang DL; Mehta H; Said JW; Yakar S; LeRoith D; Cohen P Cancer Res; 2008 May; 68(9):3342-9. PubMed ID: 18451161 [TBL] [Abstract][Full Text] [Related]
33. Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer. Powolny AA; Bommareddy A; Hahm ER; Normolle DP; Beumer JH; Nelson JB; Singh SV J Natl Cancer Inst; 2011 Apr; 103(7):571-84. PubMed ID: 21330634 [TBL] [Abstract][Full Text] [Related]
34. Dietary tomato inhibits angiogenesis in TRAMP prostate cancer but is not protective with a Western-style diet in this pilot study. Applegate CC; Lowerison MR; Hambley E; Song P; Wallig MA; Erdman JW Sci Rep; 2021 Sep; 11(1):18548. PubMed ID: 34535690 [TBL] [Abstract][Full Text] [Related]
35. Genetic ablation of the amplified-in-breast cancer 1 inhibits spontaneous prostate cancer progression in mice. Chung AC; Zhou S; Liao L; Tien JC; Greenberg NM; Xu J Cancer Res; 2007 Jun; 67(12):5965-75. PubMed ID: 17575167 [TBL] [Abstract][Full Text] [Related]
36. A 10% Tomato Diet Selectively Reduces Radiation-Induced Damage in TRAMP Mice. Rowles JL; Wallig MA; Selting KA; Fan TM; Miller RJ; O'Brien WD; Erdman JW J Nutr; 2021 Nov; 151(11):3421-3430. PubMed ID: 34386819 [TBL] [Abstract][Full Text] [Related]
37. Association of anti-inflammatory and antiangiogenic therapies negatively influences prostate cancer progression in TRAMP mice. Mateus PAM; Kido LA; Silva RS; Cagnon VHA; Montico F Prostate; 2019 Apr; 79(5):515-535. PubMed ID: 30585351 [TBL] [Abstract][Full Text] [Related]